Navigation Links
NewYork-Presbyterian/Weill Cornell creates world-class cancer center
Date:2/5/2008

NEW YORK (Feb. 5, 2008) -- NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created an expanded cancer program dedicated to advancing research, prevention and treatment of the disease. The new Cancer Center is led by renowned cancer physician-scientist Dr. Andrew Dannenberg.

A joint initiative of Weill Cornell Medical College and NewYork-Presbyterian Hospital, the Center will create strengthened and expanded research programs and multidisciplinary collaborations.

"This bold initiative will build on our strengths to create a cancer center dedicated to improving the diagnosis and treatment of patients," says Dr. Antonio M. Gotto, Jr., the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College. "By our commitment to advancing cancer research from bench to bedside, we will fulfill our mission of unlocking scientific and medical discoveries to improve lives around the globe."

"Our goal is to transform what is already an excellent cancer program into a renowned cancer center, investing in areas where we have historic strength -- such as lymphoma, lung cancer, genitourinary and preventive oncology -- while establishing new programs that can be uniquely identified with NewYork-Presbyterian/Weill Cornell," says Dr. Herbert Pardes, president and CEO of NewYork-Presbyterian Hospital.

"Cancer is the second leading cause of death in the U.S. While scientific progress continues, close to 1.5 million people will be diagnosed this year. Many of these cases will be found after the cancer has spread to other parts of the body. New ideas are desperately needed to understand why cancers form, grow and spread and how to contain them, predict them and ultimately prevent them," says Dr. David P. Hajjar, senior executive vice dean and executive vice provost of Weill Cornell Medical College and dean of Weill Cornell's Graduate School of Medical Sciences.

In conjunction with this new Center, we have committed 10 new positions for the recruitment of cancer biologists, adds Dr. Hajjar.

"The key to the success of this initiative will be collaboration and team science. Our program will facilitate interactions between physicians and scientists from a wide variety of fields -- everything from hematology and oncology to radiology, surgery, urology, genetics, pediatrics, immunology, pharmacology, even communication sciences -- helping them to create synergies that might not otherwise exist," says Dr. Dannenberg, the Henry R. Erle, M.D.Roberts Family Professor of Medicine at Weill Cornell Medical College and a leading gastroenterologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

"These multidisciplinary collaborations will extend to our colleagues at Cornell University-Ithaca, Weill Cornell Medical CollegeQatar and the Methodist Hospital in Houston, Texas," he notes.

A leading authority in cancer prevention, Dr. Dannenberg has pioneered research helping to understand the link between inflammation and cancer -- and to elucidate the mechanisms by which nonsteroidal anti-inflammatory drugs such as aspirin reduce the risk of developing certain cancers. Dr. Dannenberg has held a series of leadership positions in the American Association for Cancer Research (AACR), and serves on the editorial boards of several leading basic science and clinical oncology journals.

"We also aim to improve our physical infrastructure, with additional lab space and shared resources to stimulate the advances that are so badly needed," adds Dr. Dannenberg.


'/>"/>
Contact: Lezlie Greenberg
leg2003@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Related medicine news :

1. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
2. Weill Cornell receives $2.4 million in grants from Gates Foundation to fight tuberculosis
3. White House awards Weill Cornells Bruce McCandliss highest honor for early career scientists
4. Healthy restaurants help make us fat, says a new Cornell study
5. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
6. Bobbi Brown Cosmetics Creates Limited-Edition Lip Palette in Partnership with The Heart Truths Red Dress Collection 2008 Fashion Show
7. Bobbi Brown Cosmetics Creates Limited-Edition Red Lip Palette in Partnership With The Heart Truths 2008 Red Dress Collection
8. Gene That Creates Cerebral Cortex Discovered
9. National Heart Lung and Blood Institute creates national network to study cardiovascular disease
10. inVentiv Health Creates Client Development and Integration Team
11. Creative Technology Services Creates a New Operating Company Focused on Mobility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: